Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
3.3
2.4
Journals
Medicina
Special Issues
Advanced Technologies in Pediatric Nephrology
share announcement

Advanced Technologies in Pediatric Nephrology

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Pediatrics".

Deadline for manuscript submissions: 20 January 2025 | Viewed by 730

Special Issue Editor

Dr. Kiran K. Upadhyay

E-Mail Website
Guest Editor
Department of Pediatrics, University of Florida College of Medicine, Gainesville, FL, USA
Interests: kidney; nephrology; transplantation; hypertension; UTI; glomerulonephritis

Special Issue Information

Dear Colleagues,

In this Special Issue, we plan to provide a practical source of information about the common topics in a format that is clear to understand and accessible to all health care professionals involved in treating children and adolescents with kidney diseases. We believe that the open access nature of the journal fulfills this mission. We also aim to refine the knowledge base in pediatric nephrology, where significant advances have been made, and highlight improvements in clinical management. The study areas that we aim to cover are glomerular diseases, advances in management of pediatric hypertension, childhood nephrotic syndrome, advances in lupus nephritis, different aspects of chronic kidney disease, advances in different modalities of renal replacement therapy, advances in kidney transplantation, voiding dysfunction in children, renal tubular diseases, and genetics in renal diseases.

We will solicit original research articles, systematic reviews, meta-analyses, and reviews pertaining to these topics. 

Dr. Kiran K. Upadhyay
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pediatrics
  • kidney transplantation
  • dialysis
  • hypertension
  • nephrotic syndrome
  • glomerulonephritis
  • lupus nephritis
  • chronic kidney disease
  • voiding dysfunction
  • renal tubular disease

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Other

8 pages, 1046 KiB  
Case Report
Association of Oral Tobacco-Free Nicotine Delivery Product with Acute Renal Tubular Necrosis
by Ratna Acharya, William Clapp and Kiran Upadhyay
Medicina 2024, 60(11), 1846; https://doi.org/10.3390/medicina60111846 - 9 Nov 2024
Viewed by 507
Abstract
Usage of novel non-tobacco oral nicotine delivery products (ONDPs) has been increasing among adolescents in the United States. It is presumed that they are less toxic than their tobacco-containing counterparts, but that has not been examined in controlled studies. Most of the studies [...] Read more.
Usage of novel non-tobacco oral nicotine delivery products (ONDPs) has been increasing among adolescents in the United States. It is presumed that they are less toxic than their tobacco-containing counterparts, but that has not been examined in controlled studies. Most of the studies have focused on non-renal manifestations of tobacco consumption via different means. The renal manifestations of non-tobacco ONDPs are not very well known, especially in immunocompromised patients. A 19-year-old male transplant recipient presented with flank pain and a few days’ history of intake of ZYNR pouches. Immunosuppression was with tacrolimus, mycophenolate, and steroids. Baseline serum creatinine was 1.1–1.3 mg/dL. Laboratory evaluation showed elevated C-reactive protein, increased serum creatinine and blood urea nitrogen, leukocytosis, neutrophilia, and increased lactate dehydrogenase (LDH). Infectious disease work-up was negative. A kidney transplant biopsy showed severe acute tubular injury/necrosis (ATN) without evidence of rejection. Donor-specific antibodies were negative. Other etiologies of hemolysis were negative. He did not require renal replacement therapy. Kidney function and LDH improved gradually. The most recent follow-up eight months after presentation showed a serum creatinine level of 2.6 mg/dL with stable electrolytes, with eGFR of 35 mL/min/1.73 m2. Here, we describe a 19-year-old adolescent with a kidney transplant who sustained ATN leading to advanced chronic disease apparently following the usage of non-tobacco ONDP. Further larger studies are needed to study ATN as a possible renal manifestation of these next-generation products to raise awareness among the public. Full article
(This article belongs to the Special Issue Advanced Technologies in Pediatric Nephrology)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

Title: Pediatric Nephrology
Authors: Carlos Araya
Affiliation: Nemours Childrens Health, Orlando, FL, USA

Title: Lupus nephritis
Authors: Nisha Mathews
Affiliation: Nemours Childrens Health, Orlando, FL, USA

Title: Different modalities of renal replacement therapy
Authors: Aura Arenas Morales
Affiliation: Nemours Childrens Health, Orlando, FL, USA,

Title: Pediatric Nephrology
Authors: Naile Tufan Pekkucuksen
Affiliation: Childrens Mercy Hospital, Kansas City, MO, USA

Title: Pediatric Urology
Authors: Cynthia Sharadin
Affiliation: University of Florida, Gainesville, FL, USA

Title: Pediatric Nephrology
Authors: Ahmad Aldughiem
Affiliation: Dayton Childrens Hospital, Dayton, OH, USA

Back to TopTop